A Non–D2-Receptor-Binding Drug, An oral compound, SEP-363856 for the Treatment of Schizophrenia. 정신분열증 치료를 위한 비-D2 수용체 결합 약물, 경구용 화합물,

An oral compound, SEP-363856, that does not act on dopamine D2 receptors but has agonist activity at trace amine–associated receptor 1 (TAAR1) and 5-hydroxytryptamine type 1A (5-HT_1A) receptors, may represent a new class of psychotropic agent for the treatment of psychosis in schizophrenia.